Inventor · disambiguated record
Alexander Shneider
Also filed as: SHNEIDER ALEXANDER · SHNEIDER ALEXANDER M
4 granted patents·17 pending applications·5 citations·filing 2003–2024
66Inventor score
Top patents by PatentIndex Score
21 records- 0182US10716837B2Methods and compositions relating to P62 for the treatment and prophylaxis of cancerCURELAB ONCOLOGY INC·Filed 2016·Granted Jul 21, 2020·3 cites·18 claims
- 0269US11098098B2Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseasesCURELAB ONCOLOGY INC·Filed 2018·Granted Aug 24, 2021·1 cites·6 claims
- 0360US9717781B2Methods and compositions relating to P62 for the treatment and prophylaxis of cancerSHNEIDER ALEXANDER·Filed 2012·Granted Aug 1, 2017·1 cites·14 claims
- 0460US2021174900A1Methods for Introducing Mutations That Alter the Probability of Intranucleic Acid Base Pairing of a Conserved Structured Nucleotide and Related CompositionsCURELAB INC·Filed 2020·Application pending·0 cites
- 0558US2022009985A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0657US2020338176A1Methods and compositions relating to p62 for the treatment and prophylaxis of cancerCURELAB ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0756US2025332186A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0855US2022074958A1Methods of monitoring safety of quercetin compositionsPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICA·Filed 2021·Application pending·0 cites
- 0954US2007122430A1Influenza vaccine compositions and methods of use thereofCURE LAB INC·Filed 2006·Application pending·0 cites
- 1053US2007116717A1Influenza vaccine compositions and methodsSHNEIDER ALEXANDER M·Filed 2006·Application pending·0 cites
- 1152US11156623B2Methods of monitoring safety of quercetin compositionsPUBLIC JOINT STOCK COMPANY “SCIENTIFIC IND CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PLA·Filed 2018·Granted Oct 26, 2021·0 cites·19 claims
- 1250US2005013826A1Vaccine compositions and methodsFiled 2004·Application pending·0 cites
- 1349US2004180058A1Vaccine compositions and methodsFiled 2003·Application pending·0 cites
- 1447US2021220437A1Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular DegenerationCURELAB ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1547US2016324944A1Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseasesVENANZI FRANCO·Filed 2014·Application pending·0 cites
- 1642US2016364524A1Methods for introducing mutations that alter the probability of intranucleic acid base pairing of a conserved structured nucleotide and related compositionsCHURSOV ANDREY·Filed 2015·Application pending·0 cites
- 1740US2014095969A1Method of Referencing and Citing Scientific PapersSHNEIDER ALEXANDER·Filed 2012·Application pending·0 cites
- 1836US2006198759A1Universal test-tube rack for chemical and biochemical sample preparationSHNEIDER ALEXANDER M·Filed 2005·Application pending·0 cites
- 1936US2020197355A1Methods, compositions and containers for reducing solid form quercetin degradation and 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid toxic byproducts thereofPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PL·Filed 2018·Application pending·0 cites
- 2036US2020197354A1Methods, compositions and containers for reducing solid form quercetin degradation and 2,4,6-trihydroxybenzoic acid toxic byproduct thereofPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL P·Filed 2018·Application pending·0 cites
- 2135US2006177936A1Apparatus and methods for chemical and biochemical sample preparationSHNEIDER ALEXANDER M·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexander Shneider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →